- Investing Ideas
- Australian Pharmaceuticals & Biotech Profitable Climbers
Australian Pharmaceuticals & Biotech Profitable Climbers
Results
2
0 new
2 companies
Clinuvel Pharmaceuticals
Market Cap: AU$461.9m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$9.16
7D
0.8%
1Y
-15.6%
Neuren Pharmaceuticals
Market Cap: AU$1.6b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$12.48
7D
2.0%
1Y
18.5%